Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc.
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its...
Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Dec 31, 2020 9:27am
RE:RE:RE:RE:Kane latest presentation (Dec.16th,2020) - Link
you are correct... either way it's a win but I'm hoping page 8
(1917)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Dec 30, 2020 7:39pm
RE:RE:RE:Kane latest presentation (Dec.16th,2020) - Link
So slides 8 and 14 differ. Which is correct?
IAMGOLD Reports First Quarter 2024 Results
posted May 10, 2024 9:00am by
IAMGOLD Corp
-
|
"IAMGOLD started 2024 with very strong performance across its operations, projects and in health and safety," said Renaud Adams, President and Chief Executive Officer of IAMGOLD. "At its operations, the Company reported attributable production of 151,000 ounces. This outperformance was driven by stable operations and positive grade reconciliation at Essakane, coupled with Westwood achieving its highest quarter of ...read more
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Dec 30, 2020 7:06pm
RE:RE:Kane latest presentation (Dec.16th,2020) - Link
actually states ..."DispersinB® Wound Care biofilm wash PMA or BLA 1st Wound Care Bioburden claims Launching in 2022 2024 Sales projections
...more
(65)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Dec 21, 2020 10:46pm
RE:RE:Kane latest presentation (Dec.16th,2020) - Link
Its nice to be invested in a solid well resourced Canadian BioTech company with solid transparent partner deals in place and products that are commercialized, with rigid business plans and financing
...more
(1917)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Dec 18, 2020 11:44am
RE:Kane latest presentation (Dec.16th,2020) - Link
By Q2 2021 Kane will sign a partnership with US co. where US co. will pay $7 million Cdn to Kane for a 10% ownership in the partnership valuing this part of Kane business at $70 million.
...more
(103)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Dec 17, 2020 2:37pm
Kane latest presentation (Dec.16th,2020) - Link
This biotech is very well managed (I said it many times over the last few years and it's true...). Please find a link below to the latest presentation from Kane, you will find new information in
...more
(65)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Dec 16, 2020 10:21pm
RE:RE:Kane Announces Launch of New Human Health OTC DermaKB
Marc and the group have a plan and are well resourced. He brings in the right professionals and listens to them. Products are unique, complementary and have a niche. They are implementing
...more
(1917)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Dec 10, 2020 10:02am
RE:Kane Announces Launch of New Human Health OTC DermaKB
Just placed an order. 25% off and free shipping with coupon code Grand25
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Dec 10, 2020 8:40am
RE:Kane Announces Launch of New Human Health OTC DermaKB
the 4500 will be a decent starting point for word-of-mouth advertising. This market is huge. “The launch of our DermaKB™ line is a major milestone for Kane as it marks our first commercialized
...more
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Post by
StoneMan45
on Dec 10, 2020 8:34am
Kane Announces Launch of New Human Health OTC DermaKB
Kane Biotech Announces Launch of New Human Health OTC DermaKB™ Product Line December 10, 2020 https://ir.kanebiotech.com/press-releases/detail/277/kane-biotech-announces-launch-of-new
...more
(65)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Post by
MirrorWorldMan
on Nov 26, 2020 11:20am
On course...
During one of the recent interviews Marc politely mentioned his disfavour in further dilution and seeked alternative funding avenues. Seeing the large asks blocking share price gains must
...more
(103)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Nov 11, 2020 3:23pm
It's alive!!!
Finally some volume today as the price is still in the $0,14-0,15 range....can't wait to see the next financials (was on Nov.14 last year). GLTA
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Post by
StoneMan45
on Oct 28, 2020 1:13pm
Kane , a company in rapid growth
https://money.tmx.com/en/quote/KNE/news/5388866760612046/Kane_Biotech_builds_upon_successful_results_with_launch_of_a_US_Consumer_Test This large-scale, multi-product test will focus on US
...more
(65)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Oct 13, 2020 3:58pm
RE:STEM Animal Health Appoints New President and CEO
Kane is one of the few BioTechs I own that has serious legs to stand and build upon. They are definitely at a time in their history where they legitimately can seek new investor via refined company
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract